Francis K L Chan
Francis K L Chan
Jaffer A Ajani
Jaffer A Ajani
The progress that has been made against esophageal carcinoma is limited. Many relevant issues remain. Herein the author discusses his outlook for the treatment of this disease, which has a steadily rising incidence.
Sandra Tomaszek,Stephen D Cassivi
Sandra Tomaszek
Esophageal cancer is an aggressive disease with an overall poor prognosis. Esophagectomy remains a key therapeutic option in treating patients who have this disease. Tailoring the surgical approach to the patient and the nature of his or he...
Traditional Chinese medicinal herbs in the treatment of patients with esophageal cancer: a systematic review [0.03%]
中医药治疗食管癌患者的临床疗效系统评价
Taixiang Wu,Xunzhe Yang,Xiaoxi Zeng et al.
Taixiang Wu et al.
Traditional Chinese medicines are sometimes used as an adjunct to radiotherapy or chemotherapy for esophageal cancer. These medicines may have a benefit on the survival and quality of life of patients who have advanced esophageal cancer. Ev...
Geoffrey Y Ku,David H Ilson
Geoffrey Y Ku
This article examines the role of combined-modality therapy for treating locally advanced esophageal cancer. Although surgery remains a cornerstone of treatment, recent studies have demonstrated that pre- or perioperative chemotherapy is as...
New treatments, new challenges: pathology's perspective on esophageal carcinoma [0.03%]
新治疗，新挑战——病理学视角下的食管癌
Jennifer R Scudiere,Elizabeth A Montgomery
Jennifer R Scudiere
While frank esophageal carcinoma rarely presents a diagnostic challenge, early lesions are often tricky to assess. This difficulty stems in part from drawbacks in the classification systems designed to stratify early lesions as a guide for ...
The role of FDG-PET and staging laparoscopy in the management of patients with cancer of the esophagus or gastroesophageal junction [0.03%]
氟脱氧葡萄糖正电子发射断层扫描和分期腹腔镜在食管或胃食管交界部癌治疗中的作用
Harry H Yoon,Val J Lowe,Stephen D Cassivi et al.
Harry H Yoon et al.
The effort to improve outcomes in esophageal cancer has included attempts at improving staging and patient selection. 2-Deoxy-2-[(18)F]fluoro-Dglucose positron emission tomography (FDG-PET) has been extensively studied in this context and h...
Alan Brijbassie,Vanessa M Shami
Alan Brijbassie
Esophageal malignancy is a major source of morbidity and mortality, despite the recently increased attention to screening and early detection. Prognosis for esophageal cancer remains grim, with advanced tumor stage and lymph node metastases...
Winson Y Cheung,Geoffrey Liu
Winson Y Cheung
Investigations into inherited genetic variations in the DNA code (known as polymorphisms) in the field of oncology have provided preliminary support for an association with cancer risks and outcomes. Early studies have highlighted several g...
Yutaka Tomizawa,Kenneth K Wang
Yutaka Tomizawa
The incidence of esophageal cancer, especially esophageal adenocarcinoma, is increasing and its high mortality rate is a notable fact. Improving survival rates of this disease depend on earlier detection through screening and surveillance; ...